The Decision

In some instances, such as when someone has an unknown genetic disease, sequencing the genome makes sense to get to the cause of the disease, the Wall Street Journal says, but it adds: What about when people are healthy? Stanford University's Atul Butte and Robert Green from Brigham and Women's Hospital and Harvard Medical School take up the debate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Source of the Fever

Staying Well

To Tell?

Better Methods Needed

The Google Study

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.